Article Text
Articles
Clofibrate in the treatment and prevention of ischaemic heart disease: recent trials
Abstract
Clofibrate (Atromid-S) reduces serum lipid concentrations in man.1 The results of two large trials of clofibrate in the long-term management of patients with ischaemic heart disease were published last year and have caused much discussion.2 3